Virtus LifeSci Biotech Clinical Trials ETF (BBC)

NYSE Arca: BBCExchange-traded fund from Virtus.

  • Expense ratio0.75%
  • Net assets$39.2M
  • Dividend yield1.41%
  • 1-year return+36.70%
  • Holdings125

BBC ETF price chart

BBC quote & trading statistics

BBC performance

Total return · as of October 17, 2026
  • YTD+6.78%
  • 1 year+36.70%
  • 3 years+31.96%/yr
  • 5 years-1.34%/yr
  • 10 years+7.64%/yr
1Y volatility
32.66%
3Y volatility
35.18%
3Y Sharpe ratio
0.87

Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.

BBC top 10 holdings

#SymbolNameWeight
1KODKodiak Sciences Inc2.23%
2ABCLAbcellera Biologics Inc1.82%
3TRAXFirst Tracks Biotherapeutics1.65%
4XNCRXencor Inc1.61%
5AMLXAmylyx Pharmaceuticals Inc1.56%
6NRIXNurix Therapeutics Inc1.28%
7ORICOric Pharmaceuticals Inc1.21%
8MBXMBX Biosciences, Inc. Common Stock1.17%
9FDMT4D Molecular Therapeutics Inc1.13%
10PCVXVaxcyte Inc1.11%

The top 10 holdings make up 14.8% of the fund (125 holdings in total). As of October 17, 2026.

BBC sector weights

Healthcare
100.0%

BBC region weights

North America
94.5%
Europe Developed
4.4%
United Kingdom
2.2%
Asia Emerging
0.6%

BBC asset allocation

U.S. stocks
89.8%
Non-U.S. stocks
10.1%
Cash
0.1%

BBC market-cap breakdown

Micro cap
68.2%
Small cap
22.6%
Mid cap
2.9%

About Virtus LifeSci Biotech Clinical Trials ETF

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

BBC ETF FAQ

What is the BBC expense ratio?

Virtus LifeSci Biotech Clinical Trials ETF has a net expense ratio of 0.75%, or $75.00 a year for every $10,000 invested.

How much money is in BBC?

Virtus LifeSci Biotech Clinical Trials ETF has about $39.2M in net assets.

What are the top holdings of BBC?

The largest positions in BBC are Kodiak Sciences Inc (2.23%), Abcellera Biologics Inc (1.82%), First Tracks Biotherapeutics (1.65%). The fund holds 125 securities in total.

How has BBC performed?

BBC returned +36.70% over the past year and -1.34% a year over the past five years, including reinvested distributions.

Does BBC pay dividends?

BBC has a dividend yield of 1.41% and pays distributions na.

When was BBC launched?

Virtus LifeSci Biotech Clinical Trials ETF began trading on December 16, 2014.